J&J skin care buy
This article was originally published in The Rose Sheet
Executive Summary
Johnson & Johnson Consumer France SAS has entered into an agreement to acquire French skin care marketer Groupe Vendome, company reports March 23. Groupe Vendome's portfolio of adult and baby care brands include Le Petit Marseillais, a line of shower gels, soaps, baths and hair care products, Laboratories Vendome, a dermatologist-positioned collection, and Prim'Age baby toiletries. Deal is expected to close in the second quarter, according to J&J...
You may also be interested in...
Finance In Brief
J&J Q3: U.S. consumer sales were $1.14 bil. in the third quarter, representing an increase of 5.9% over the prior-year period, Johnson & Johnson announces Oct. 17. Worldwide consumer sales were $2.46 bil., an increase of 10.1% over the prior year, boosted in part by the international growth of skin care products primarily reflecting the recent acquisition of French skin care marketer Groupe Vendome (1"The Rose Sheet" March 27, 2006, In Brief). The sales performance included a 2% positive impact from currency...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.